Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Solithromycin shows potential against Plasmodium spp. and Mycobacterium leprae

Nov. 23, 2010

Promising new antimalarial candidates investigated in preclinical testing

Nov. 22, 2010

Lilly describes activity of LY-2606368, now in phase I testing

Nov. 22, 2010

Apilimod mesilate has limited efficacy in phase II trial in rheumatoid arthritis

Nov. 22, 2010

Proof-of-concept secukinumab trial in ankylosing spondylitis meets primary endpoint

Nov. 19, 2010

AC-430 confers protection in models of autoimmune and inflammatory conditions

Nov. 19, 2010

EVX-001650 displays antipsychotic activity in mouse models related to schizophrenia

Nov. 19, 2010

Clinical development of ChimeriVax-Dengue vaccine updated

Nov. 19, 2010

Typhoid fever vaccine Vi-TT is safe in pediatric and juvenile subjects

Nov. 18, 2010

Switch pocket kinase inhibitors DP-4610, DP-3556 and DP-4178 show promise in models of RA

Nov. 18, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...